Skip to content

Cardiovascular diseases

Detect risk in a heartbeat

Hereditary factors can play a significant role in illness predisposition. The parents, children, and siblings of someone with a cardiovascular disease-causing genetic variant often run a 50 percent risk of having the same variant.

Early detection through personalized genetic testing has the potential to save lives. For clinicians, DNA testing can help decide the most effective course of patient treatment, identify family members at risk and provide vital diagnostic and prognostic information.

Get in touch

Detect early, save lives

Identify family risk
It is important to detect cardiovascular diseases as early as possible so that clinical management can be initiated.

Genetic testing can help decide the most effective course of treatment for a patient, identify family members at risk and provide other diagnostic and prognostic information.

Treat or eliminate
If a hereditary factor is identified, family members who carry the variant can be identified through cascade testing. Positive results enable early treatment and monitoring of at-risk family members.
For the many who return negative results, the need for ongoing clinical screening can be eliminated with full peace of mind

Target multiple disorders
Diagnostic tests help identify hereditary risk factors associated with developing cardiovascular diseases such as atherosclerosis and venous thrombosis. They can also detect elevated risk of familial hypercholesterolemia and thrombophilia.

sample-close-up
test-tube-icon

One tube per patient sample - no sample splitting

45

Less than 45 minutes hands-on time

CE-IVD

CE-IVD certified solution – from sample to result

Risk factor detection

Our genetic testing solutions allow clinicians to detect multiple genetic risk factors for cardiovascular disease, paving the way for more effective diagnosis and treatment.

Devyser’s test kits enable cascade screening of monogenic and polygenic familial hypercholesterolemia, thrombophilia and other cardiovascular conditions.

A single-tube workflow reduces handling time from hours to minutes and ensures fast results.

IM-2022-NGS_5

The latest from the Devyser blog

View all

What are the latest trends in genetic screening for cardiovascular diseases, and what does scientific research mean for you and your laboratory? Discover more here